Overexpression of receptor Notch-1, or its ligand Jagged-1, has been shown to predict poor survival of breast cancer patients [67],[68], suggesting a significant role of the Notch pathway in this malignant disease. The gene discussed is NOTCH1; the disease is breast cancer.